Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Astria Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -35.82M | -36.99M | -29.59M | -29.01M | -28.8M | -24.15M | -34.2M | -20.24M | -15.1M | -13.49M | -14.29M | -12.39M | -11.45M | -15.27M | -9.51M | -7.9M | -7.49M | -170.09M |
Interest Income | 2.89M | 3.35M | 3.96M | 4.52M | 4.65M | 4.24M | 2.8M | 2.53M | 2.56M | 2.32M | 1.02M | 437K | 214K | 56K | 33K | 35K | 40K | 14K |
Pretax Income | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M | -12M | -11.25M | -15.32M | -9.49M | -7.87M | -7.47M | -170.08M |
Net Income | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -12.24M | -12M | -11.25M | -15.21M | -9.49M | -7.87M | -7.47M | -170.08M |
Selling & General & Admin | 9.88M | 9.21M | 9.43M | 8.5M | 8.09M | 8.42M | 7.33M | 6.9M | 6.01M | 5.46M | 4.7M | 4.69M | 4.83M | 5.02M | 3.81M | 4.11M | 4.01M | 2.88M |
Research & Development | 25.95M | 27.79M | 20.16M | 20.51M | 20.71M | 15.73M | 11.67M | 13.34M | 9.09M | 8.03M | 9.59M | 7.7M | 6.62M | 10.36M | 5.69M | 3.79M | 3.48M | 2.59M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20K | n/a | 9K | -48K | -15K | -1K | -16K | -8K | -20K | 1K |
Operating Expenses | 35.82M | 36.99M | 29.59M | 29.01M | 28.8M | 24.15M | 19M | 20.24M | 15.1M | 13.49M | 14.29M | 12.39M | 11.45M | 15.38M | 9.51M | 7.9M | 7.49M | 5.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 35.82M | 36.99M | 29.59M | 29.01M | 28.8M | 24.15M | 34.2M | 20.24M | 15.1M | 13.49M | 14.29M | 12.39M | 11.45M | 15.38M | 9.51M | 7.9M | 7.49M | 5.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -43.28K | n/a | n/a | n/a | n/a | -1.03M | n/a | n/a | -111K | -17K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M | 13.74M | 13.02M | 13.02M | 12.83M | 12.83M | 5.98M | 3.73M |
Shares Outstanding (Diluted) | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M | 13.74M | 13.02M | 13.02M | 12.83M | 12.83M | 5.98M | 3.73M |
EPS (Basic) | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 | -0.63 | -0.45 | -0.4 | -0.66 | -0.87 | -0.86 | -1.17 | -0.74 | -0.61 | -1.25 | -45.6 |
EPS (Diluted) | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 | -0.63 | -0.45 | -0.4 | -0.66 | -0.87 | -0.86 | -1.17 | -0.74 | -0.61 | -1.25 | -45.6 |
EBITDA | -35.82M | -36.99M | -29.59M | -29.01M | -28.8M | -24.15M | -34.2M | -20.24M | -15.1M | -13.49M | -14.29M | -12.39M | -11.45M | -15.38M | -9.51M | -7.9M | -7.49M | -5.47M |
EBIT | -33.05M | -36.99M | -29.59M | -29.01M | -28.8M | -24.15M | -19M | -20.24M | -15.1M | -13.49M | -14.29M | -12.39M | -11.45M | -15.38M | -9.51M | -7.9M | -7.49M | -5.47M |
Depreciation & Amortization | n/a | n/a | -43.28K | n/a | n/a | 43.28K | -15.2M | -39.59K | 122.08K | n/a | -1.35M | n/a | 86.06K | -111K | 200K | 7.9M | 7.49M | 5.27M |